Marie Tullberg1, Malin Ernberg. 1. Department of Clinical Oral Physiology, Institute of Odontology, Karolinska Institutet, Huddinge, Sweden. marie.tullberg@brahekliniken.se
Abstract
OBJECTIVE: The aim of the study was to investigate the presence of symptoms and signs of temporomandibular disorders (TMD) in patients with tinnitus and to evaluate the effect of TMD treatment on tinnitus in a long-term perspective in comparison with a control group of patients on a waiting list. MATERIAL AND METHODS: One-hundred-and-twenty patients with tinnitus were subjected to a clinical examination of the masticatory system and whether they had co-existing TMD to TMD treatment. Ninety-six patients had TMD, most frequently localized myalgia. Seventy-three of these completed the treatment and responded to a questionnaire 2 years later. Fifty patients with tinnitus who were on the waiting list served as a control group. RESULTS: Eighty percent of the patients had signs of TMD, most commonly myofascial pain. Forty-three percent of the patients reported that their tinnitus was improved at the 2-year follow-up, 39% that it was unchanged, and 17% that it was impaired compared to before the treatment. Twelve percent of the subjects in the control group reported that their tinnitus was improved compared to 2 years previously, 32% that it was unchanged, and 56% that it was impaired. The difference between groups was significant (chi(2): p<0.001). CONCLUSION: The results of this study showed that TMD symptoms and signs are frequent in patients with tinnitus and that TMD treatment has a good effect on tinnitus in a long-term perspective, especially in patients with fluctuating tinnitus.
OBJECTIVE: The aim of the study was to investigate the presence of symptoms and signs of temporomandibular disorders (TMD) in patients with tinnitus and to evaluate the effect of TMD treatment on tinnitus in a long-term perspective in comparison with a control group of patients on a waiting list. MATERIAL AND METHODS: One-hundred-and-twenty patients with tinnitus were subjected to a clinical examination of the masticatory system and whether they had co-existing TMD to TMD treatment. Ninety-six patients had TMD, most frequently localized myalgia. Seventy-three of these completed the treatment and responded to a questionnaire 2 years later. Fifty patients with tinnitus who were on the waiting list served as a control group. RESULTS: Eighty percent of the patients had signs of TMD, most commonly myofascial pain. Forty-three percent of the patients reported that their tinnitus was improved at the 2-year follow-up, 39% that it was unchanged, and 17% that it was impaired compared to before the treatment. Twelve percent of the subjects in the control group reported that their tinnitus was improved compared to 2 years previously, 32% that it was unchanged, and 56% that it was impaired. The difference between groups was significant (chi(2): p<0.001). CONCLUSION: The results of this study showed that TMD symptoms and signs are frequent in patients with tinnitus and that TMD treatment has a good effect on tinnitus in a long-term perspective, especially in patients with fluctuating tinnitus.
Authors: Annemarie van der Wal; Paul Van de Heyning; Annick Gilles; Laure Jacquemin; Vedat Topsakal; Vincent Van Rompaey; Marc Braem; Corine Mirjam Visscher; Steven Truijen; Sarah Michiels; Willem De Hertogh Journal: Front Neurosci Date: 2020-09-16 Impact factor: 4.677
Authors: Massimo Ralli; Antonio Greco; Rosaria Turchetta; Giancarlo Altissimi; Marco de Vincentiis; Giancarlo Cianfrone Journal: J Int Med Res Date: 2017-05-28 Impact factor: 1.671
Authors: Haúla F Haider; Derek J Hoare; Raquel F P Costa; Iskra Potgieter; Dimitris Kikidis; Alec Lapira; Christos Nikitas; Helena Caria; Nuno T Cunha; João C Paço Journal: Front Neurosci Date: 2017-04-28 Impact factor: 4.677
Authors: Sarah Michiels; Tanit Ganz Sanchez; Yahav Oron; Annick Gilles; Haúla F Haider; Soly Erlandsson; Karl Bechter; Veronika Vielsmeier; Eberhard Biesinger; Eui-Cheol Nam; Jeanne Oiticica; Ítalo Roberto T de Medeiros; Carina Bezerra Rocha; Berthold Langguth; Paul Van de Heyning; Willem De Hertogh; Deborah A Hall Journal: Trends Hear Date: 2018 Jan-Dec Impact factor: 3.293
Authors: Sarah Michiels; Sebastiaan Naessens; Paul Van de Heyning; Marc Braem; Corine M Visscher; Annick Gilles; Willem De Hertogh Journal: Front Neurosci Date: 2016-11-29 Impact factor: 4.677
Authors: Massimo Ralli; Antonio Greco; Armando Boccassini; Giancarlo Altissimi; Carlo Di Paolo; Vincenzo Falasca; Armando De Virgilio; Antonella Polimeni; Giancarlo Cianfrone; Marco de Vincentiis Journal: PLoS One Date: 2018-08-13 Impact factor: 3.240
Authors: Annemarie Van der Wal; Sarah Michiels; Paul Van de Heyning; Marc Braem; Corine Visscher; Vedat Topsakal; Annick Gilles; Laure Jacquemin; Vincent Van Rompaey; Willem De Hertogh Journal: J Clin Med Date: 2020-03-05 Impact factor: 4.241